Inovio and coherus announce clinical collaboration to advance development of ino-3112 in combination with loqtorzi™ (toripalimab-tpzi)

-  combination therapy to be evaluated in a phase 3  trial in patients with locoregionally advanced ,  high-risk ,  hpv16/18 - positive head and neck cancer plymouth meeting, pa. and redwood city, calif.
INO Ratings Summary
INO Quant Ranking